Virtual Event

Fireside Chat: The Future of Clinical Trials and Site Engagement

The COVID-19 pandemic has proven that research can be done more efficiently. To make these efficiencies sustainable, the sites’ perspective must be considered. Sponsors, CROs, and sites should engage early…

Blog

Introducing Fireside Chats: Conversations On Burning Research Topics

July 2, 2020

Advarra is excited to introduce Fireside Chats, a series of virtual conversations discussing current issues in clinical trials. Each Fireside Chat brings together perspectives from across the research community, enabling…

Blog

Q&A Part 1 – Gene Therapy Research in the Age of COVID-19

June 17, 2020

In Advarra’s inaugural virtual symposium, experts from industry and academia met to discuss the unique challenges gene therapy research poses for research sites, sponsors, CROs, and study participants.

Blog

Q&A Part 2 – Gene Therapy Research in the Age of COVID-19

June 17, 2020

In Advarra’s inaugural virtual symposium, industry and academic experts discussed overcoming obstacles and optimizing study startup in gene therapy research. They respond to more popular Q&A topics here.

Virtual Event

Virtual Symposium: Gene Therapy Research in the Age of COVID-19

Gene therapy research is expanding rapidly in the clinical setting, especially in oncology, rare diseases, and infectious diseases—in fact, gene therapy research plays a crucial role in responding to the…

Blog

Safety Precautions for Laboratory Research With COVID-19 Specimens

May 27, 2020

The current global pandemic has brought biosafety to the spotlight. Biosafety practices must be customized to the proposed research as well as the existing facility and local regulatory requirements.

Blog

Virtual Symposium: Gene Therapy Research in the Age of COVID-19

May 13, 2020

Gene therapy research continues its rapid expansion in the clinical setting, especially in infectious disease, rare disease, and oncology. To support discussion of emerging genetic research issues, Advarra presents its…

Abstract

Safety Precautions for Laboratory Research with SARS-CoV-2 Positive Specimens and COVID-19 Subjects

May 12, 2020

Daniel Eisenman, PhD, RBP, SM(NRCM), CBSP, Director of Biosafety Services, contributed to the article Safety Precautions for Laboratory Research with SARS-CoV-2 Positive Specimens and COVID-19 Subjects in Clinical Researcher.

Blog

How Sites Can Prepare for COVID-19 Genetically Engineered Vaccine Studies

April 15, 2020

Currently the most prominent coronavirus vaccine candidates contain engineered genetic material. Sites wishing to participate in this research should be prepared for the additional requirements of research involving genetic engineering.

Info Sheet

IBC Review and Consulting Services

September 30, 2019

No more waiting for a standing meeting. No submission deadlines. Responsive and flexible—only 10 business days or less from submission to institutional biosafety committee (IBC) review.